Madsen Torsten M. 4
4 · Aptinyx Inc. · Filed Jun 26, 2018
Insider Transaction Report
Form 4
Aptinyx Inc.APTX
Madsen Torsten M.
Chief Medical Officer
Transactions
- Conversion
Common Stock
2018-06-25+2,328→ 226,089 total - Conversion
Common Stock
2018-06-25+1,801→ 230,550 total - Conversion
Series A-2 Convertible Preferred Stock
2018-06-25−73,384→ 0 total→ Common Stock (2,660 underlying) - Conversion
Series B Convertible Preferred Stock
2018-06-25−49,702→ 0 total→ Common Stock (1,801 underlying) - Conversion
Common Stock
2018-06-25+2,660→ 228,749 total - Purchase
Common Stock
2018-06-25$16.00/sh+1,000$16,000→ 231,550 total - Conversion
Series A-1 Convertible Preferred Stock
2018-06-25−64,212→ 0 total→ Common Stock (2,328 underlying)
Footnotes (2)
- [F1]Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.
- [F2]On June 25, 2018, the Reporting Person purchased 1,000 shares of common stock of the Issuer at a price of $16.00 per share pursuant to an underwritten public offering.